Fierce Pharma Feature: Small molecule biomarkers in precision medicine
Por um escritor misterioso
Descrição
This contributed piece to Fierce Pharma discusses small molecule biomarkers & how next-gen mass spectrometry is enabling their discovery on an entirely new scale.
Translational precision medicine: an industry perspective, Journal of Translational Medicine
The expanding role for small molecules in immuno-oncology
Large-scale pharmacogenomic studies and drug response prediction for personalized cancer medicine - ScienceDirect
Biologics, Free Full-Text
Fierce Biotech's 2022 Fierce 15
Vincent Ling on LinkedIn: Interesting article on the costs of developing precision / personalized…
A precision medicine–based, 'fast-fail' approach for psychiatry
Small Molecule Drug Discovery Market Growth, Size, Share And Trends Report 2032
Biomarker development in the precision medicine era: lung cancer as a case study
Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics: Trends in Pharmacological Sciences
BDCC, Free Full-Text
Frontiers Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
Biomarker development in the precision medicine era: lung cancer as a case study
Overview Archives - Sapient, Discovery Metabolomics Lab, Small Molecule Biomarkers - Sapient
de
por adulto (o preço varia de acordo com o tamanho do grupo)
